Production (Stage)
Twist Bioscience Corporation
TWST
$28.26
$0.100.36%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -24.48% | 8.83% | 59.50% | -88.10% | -5.78% |
| Total Depreciation and Amortization | 0.38% | 57.30% | -51.14% | -0.04% | 1.63% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 76.75% | -13.37% | -76.31% | 307.67% | 26.26% |
| Change in Net Operating Assets | 85.08% | -617.98% | -109.07% | 263.38% | 549.81% |
| Cash from Operations | 39.40% | -39.87% | -140.20% | 67.16% | 15.45% |
| Capital Expenditure | -82.72% | -13.29% | -107.46% | -60.03% | 59.96% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 271.31% | 2.09% | 182.28% | 105.48% | -181.77% |
| Cash from Investing | 7.16% | -19.53% | -80.73% | 86.43% | -225.81% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 8.51% | -18.84% | 24.70% | -13.35% | 253.73% |
| Repurchase of Common Stock | 16.67% | 25.00% | -14.29% | 99.54% | 36.63% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | -- | -- | -- | -- |
| Cash from Financing | -82.19% | 394.73% | 24.72% | 59.08% | 224.10% |
| Foreign Exchange rate Adjustments | 296.23% | -172.60% | 3,550.00% | 103.08% | -156.03% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -119.04% | 60.69% | -208.81% | 81.75% | -13.56% |